Depression and Anxiety Trial, Recruiting (NCT05797428)

Depression and Anxiety Trial, Recruiting NCT05797428 Sponsor: National Taiwan University Hospital Condition: Depression and Anxiety

Printed from Voxsanity (voxsanity.com.au) — NCT05797428 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Depression And Anxiety

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with a mood disorder (such as depression or bipolar disorder) by a psychiatrist.
You have taken a depression questionnaire (called the PHQ-9) and scored between 5 and 19, which suggests mild to moderately severe depression.
You are willing to take part in a type of talk therapy called logotherapy (a meaning-based counselling approach).
You are able to actively participate in logotherapy sessions.

Who may not be able to join:

You have a severe emotional or mood disorder that would make it difficult or impossible to take part in logotherapy sessions.
You are experiencing serious mental health symptoms that make it hard to tell what is real, or you have a significant intellectual impairment (confirm with trial site).
You are currently having serious thoughts of suicide or have a clear plan to end your life.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 8 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Fan-Ko Sun, PhD, Second Degree Bachelor of Science in nursing, National Taiwan University

Phone: +886-2-33669702

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05797428

Sponsor: National Taiwan University Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Depression and Anxiety

Trial contact: +886-2-33669702

More information: https://clinicaltrials.gov/study/NCT05797428

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with a mood disorder (such as depression or bipolar disorder) by a psychiatrist.
You have taken a depression questionnaire (called the PHQ-9) and scored between 5 and 19, which suggests mild to moderately severe depression.
You are willing to take part in a type of talk therapy called logotherapy (a meaning-based counselling approach).
You are able to actively participate in logotherapy sessions.

Who may not be able to join:

You have a severe emotional or mood disorder that would make it difficult or impossible to take part in logotherapy sessions.
You are experiencing serious mental health symptoms that make it hard to tell what is real, or you have a significant intellectual impairment (confirm with trial site).
You are currently having serious thoughts of suicide or have a clear plan to end your life.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 8 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

National Taiwan University Hospital

Registry

ClinicalTrials.gov

Start date

19 May 2023

Est. completion

31 July 2025

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Purpose in life Test-1; Purpose in life Test-2; Purpose in life Test-3; Purpose in life Test-4; Beck Depression Inventory II-1; Beck Depression Inventory II-2; Beck Depression Inventory II-3; Beck Depression Inventory II-4; Beck Anxiety Inventory-1; Beck Anxiety Inventory-2; Beck Anxiety Inventory-3; Beck Anxiety Inventory-4; Beck Scale for Suicide Ideation-1; Beck Scale for Suicide Ideation-2; Beck Scale for Suicide Ideation-3; Beck Scale for Suicide Ideation-4

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov